AI-Powered COVID-19 Cough Analyzer App Assesses Respiratory Health and Associated Risks
By LabMedica International staff writers Posted on 28 Aug 2020 |

Image: kAs (Photo courtesy of Zensark Technologies)
A team of scientists have repurposed an artificial intelligence/machine learning-powered cough analysis mobile app for assessing respiratory health and associated COVID-19 risks.
The mobile app called kAs has been developed by Zensark Technologies (Hyderabad, Telangana, India), in collaboration with Salcit Technologies (Hyderabad, Telangana, India), to assess respiratory health of the patients by leveraging machine learning and disease specific cough signatures. It brings the functionality of Spirometry using one's smartphone to carry out on demand assessments without the need to step out of the house. Patients can use their mobile phones to track the sound of their cough to assess and track their health.
The app has been developed based on the guidelines laid out by the WHO and asks 15 questions to the subject. The subject then cough into the mobile app which sends the cough sounds to the company’s AI platform Swaasa, where it undergoes an audiometric analysis and produces a composite COVID Risk Score, based on the answers to the questionnaire and the coughing sound. The app generates a rating on a scale of 1 to 10, with 10 being the highest risk level. The Risk Score of any individual can be tracked across multiple days or weeks. The subjects can be asked to submit cough samples as many times a day for as many days as necessary. Based on the samples and symptoms, the app tracks the risk level of each individual over time.
Anytime a subject is found to be breaching a threshold risk score, it is highlighted to public health officials on their dashboards. The dashboards are designed to show the population level statistics and can drill down to the detailed reports of an individual subject. The app also allows doctors, with an external microphone and wireless stethoscope to track various breathing and risk parameters.
Related Links:
Zensark Technologies
Salcit Technologies
The mobile app called kAs has been developed by Zensark Technologies (Hyderabad, Telangana, India), in collaboration with Salcit Technologies (Hyderabad, Telangana, India), to assess respiratory health of the patients by leveraging machine learning and disease specific cough signatures. It brings the functionality of Spirometry using one's smartphone to carry out on demand assessments without the need to step out of the house. Patients can use their mobile phones to track the sound of their cough to assess and track their health.
The app has been developed based on the guidelines laid out by the WHO and asks 15 questions to the subject. The subject then cough into the mobile app which sends the cough sounds to the company’s AI platform Swaasa, where it undergoes an audiometric analysis and produces a composite COVID Risk Score, based on the answers to the questionnaire and the coughing sound. The app generates a rating on a scale of 1 to 10, with 10 being the highest risk level. The Risk Score of any individual can be tracked across multiple days or weeks. The subjects can be asked to submit cough samples as many times a day for as many days as necessary. Based on the samples and symptoms, the app tracks the risk level of each individual over time.
Anytime a subject is found to be breaching a threshold risk score, it is highlighted to public health officials on their dashboards. The dashboards are designed to show the population level statistics and can drill down to the detailed reports of an individual subject. The app also allows doctors, with an external microphone and wireless stethoscope to track various breathing and risk parameters.
Related Links:
Zensark Technologies
Salcit Technologies
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
Channels
Clinical Chemistry
view channel
Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
Ovarian cancer is considered one of the deadliest cancers, in part because it rarely shows clear symptoms in its early stages, and diagnosis is often complex. Current approaches make it difficult to accurately... Read more
Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read moreMolecular Diagnostics
view channel
CRISPR-Based Tuberculosis Test Uses Mouth Swab to Simplify Screening
Tuberculosis remains the world’s deadliest infectious disease, with more than 10 million people falling ill annually and about 40% of cases going undiagnosed. Current testing depends on sputum samples,... Read more
New DNA Methylation-Based Method Predicts Cancer Progression
Cancer often develops silently for years before diagnosis, making it difficult to trace its origins and predict its progression. Traditional approaches to studying cancer evolution have lacked the precision... Read moreHematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read moreImmunology
view channel
Companion Diagnostic Test for CRC Patients Identifies Eligible Treatment Population
Colorectal cancer remains one of the leading causes of cancer-related deaths worldwide, and identifying which patients will benefit most from targeted immunotherapies is critical. Existing diagnostic methods... Read more
Novel Tool Uses Deep Learning for Precision Cancer Therapy
Nearly 50 new cancer therapies are approved each year, but selecting the right one for patients with highly individual tumor characteristics remains a major challenge. Physicians struggle to navigate the... Read more
Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients
Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read moreMicrobiology
view channel
Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Sepsis arises from infection and immune dysregulation, with neutrophils playing a central role in its progression. However, current clinical tools are unable to both isolate these cells and assess their... Read more
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
New Microscope Promises to Speed Up Medical Diagnostics
Traditional microscopes are designed for flat samples, yet real-life specimens, such as tissue slides, are often curved or uneven. This mismatch forces researchers to rely on scanning methods or costly... Read more
ESR Testing Breakthrough Extends Blood Sample Stability from 4 to 28 Hours
Erythrocyte sedimentation rate (ESR) is one of the most widely ordered blood tests worldwide, helping clinicians detect and monitor infections, autoimmune conditions, cancers, and other diseases.... Read more
Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma
Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more
Clinicopathologic Study Supports Exclusion of Cervical Serous Carcinoma from WHO Classification
High-grade serous carcinoma is a rare diagnosis in cervical biopsies and can be difficult to distinguish from other tumor types. Cervical serous carcinoma is no longer recognized as a primary cervical... Read moreTechnology
view channel
Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine
The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Rapid Diagnostic Technology Utilizes Breath Samples to Detect Lower Respiratory Tract Infections
Respiratory tract infections (LRTIs) are leading causes of illness and death worldwide, particularly among vulnerable populations such as the elderly, young children, and those with compromised immune systems.... Read moreIndustry
view channel
VedaBio Partners With Mammoth Biosciences to Expand CRISPR-Based Diagnostic Technologies
VedaBio (San Diego, CA, USA) has entered into a non-exclusive license agreement with Mammoth Biosciences (Brisbane, CA, USA) for the use of select CRISPR-based technologies in diagnostic applications.... Read more